The Wall Street Journal

How a surfie who never finished uni became a biotech billionaire

How a surfie who never finished uni became a biotech billionaire
Bob Duggan is now said to be worth $25.6 billion. (Image: Summit Therapeutics)
The Wall Street Journal
By David WainerThere is a myth that making money in biotechnology stocks requires an advanced degree. But Bob Duggan, an avid surfie who never graduated from university, has proven that notion wrong. Twice.Duggan’s latest investment, Summit Therapeutics, has become one of the industry’s greatest bets in recent years. The stock is up more than 1,000% in the past 12 months thanks to data from a late-stage trial that showed that its drug, Ivonescimab, beat Merck’s blockbuster cancer drug Keytruda in patients with a form of l...

More Health

How Pharmac's set-up risks higher health costs
Economy

How Pharmac's set-up risks higher health costs

Pharmac's fixed budget discourages use of cost-saving medicines common elsewhere.

Pattrick Smellie 23 Oct 2025
Solar-powered hospitals possible
Health

Solar-powered hospitals possible

Sunlight may be more than disinfectant.

Ian Llewellyn 16 Oct 2025
Southern Cross pays record 3.8 million claims
Law & Regulation

Southern Cross pays record 3.8 million claims

Rising demand and more frequent claims push up costs, directly impacting premiums.

John Anthony 30 Sep 2025
Fisher & Paykel Healthcare shares dip on new tariff fears
Markets

Fisher & Paykel Healthcare shares dip on new tariff fears

US Department of Commerce launched a “Section 232” on medical products.

Gregor Thompson 25 Sep 2025